Factorial Biotechnologies and Ginkgo Bioworks announced a new collaboration. Through this partnership, Factorial will leverage Ginkgo Enzyme Services to develop a novel isothermal DNA polymerase for use in Factorial’s single-cell next-generation sequencing library prep kit. Given its extensive expertise in this space, Ginkgo is providing these services under its success-based pricing model, created to help companies de-risk their research and development efforts. To support this promising technology, Ginkgo will lead a campaign in P. pastoris to develop a novel enzyme – isothermal DNA polymerase – instrumental to Factorial’s innovative NGS library prep kit. Ginkgo’s advanced ultra high throughput screening methods can help identify unique enzymes and valuable reagents with desired activity and functions for innovative life science tools and research. Performing discovery and high throughput screening in Ginkgo’s proprietary P. pastoris expression system enables synergy between early innovation and manufacturability of these valuable reagents.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on DNA:
- Ginkgo Bioworks and Ceres Nanosciences partner in pathogen monitoring
- Ginkgo Bioworks price target lowered to $3.50 from $5 at Raymond James
- Ginkgo Bioworks and Exacta Bioscience partner in crop protection product
- Ginkgo Bioworks (NASDAQ:DNA) Blasts Up on New Alphabet Partnership
- Ginkgo Bioworks, Google Cloud announce five-year AI partnership